These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9669002)

  • 21. Relationship between circulating high density lipoprotein concentrations and interleukin-6 release during abdominal operations.
    Fujita T; Hara A; Yamazaki Y
    Eur J Surg; 2001 May; 167(5):347-50. PubMed ID: 11419549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
    Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
    Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study.
    Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA
    Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?
    Whitten CW; Hill GE; Ivy R; Greilich PE; Lipton JM
    Anesth Analg; 1998 Jan; 86(1):28-33. PubMed ID: 9428846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass.
    Berendes E; Möllhoff T; Aken HV; Erren M; Deng MC; Loick HM
    Crit Care Med; 1997 Sep; 25(9):1527-33. PubMed ID: 9295827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass.
    Neuhof C; Wendling J; Dapper F; Bauer J; Zickmann B; Jochum M; Tillmanns H; Neuhoft H
    Shock; 2001; 16 Suppl 1():39-43. PubMed ID: 11770032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery.
    Rothenburger M; Soeparwata R; Deng MC; Berendes E; Schmid C; Tjan TD; Wilhelm MJ; Erren M; Böcker D; Scheld HH
    J Am Coll Cardiol; 2001 Jul; 38(1):124-30. PubMed ID: 11451261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfusion-related factors of endotoxin release during cardiopulmonary bypass.
    Jansen PG; Te Velthuis H; Oudemans-Van Straaten HM; Bulder ER; Van Deventer SJ; Sturk A; Eijsman L; Wildevuur CR
    Eur J Cardiothorac Surg; 1994; 8(3):125-9. PubMed ID: 8011344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli.
    Gomaraschi M; Basilico N; Sisto F; Taramelli D; Eligini S; Colli S; Sirtori CR; Franceschini G; Calabresi L
    Biochim Biophys Acta; 2005 Sep; 1736(2):136-43. PubMed ID: 16135414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients.
    Wan S; LeClerc JL; Schmartz D; Barvais L; Huynh CH; Devière J; DeSmet JM; Vincent JL
    Am Heart J; 1997 Mar; 133(3):335-9. PubMed ID: 9060803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response.
    Akgün S; Ertel NH; Mosenthal A; Oser W
    J Lab Clin Med; 1998 Jan; 131(1):103-8. PubMed ID: 9452133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative measurements of interleukin-6 and alpha-melanocyte-stimulating hormone in cardiac transplant patients.
    Sakai T; Latson TW; Whitten CW; Ring WS; Lipton JM; Giesecke AH; O'Flaherty DN
    J Cardiothorac Vasc Anesth; 1993 Feb; 7(1):17-22. PubMed ID: 8381685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.
    Jansen NJ; van Oeveren W; Gu YJ; van Vliet MH; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1992 Oct; 54(4):744-7; discussion 747-8. PubMed ID: 1417233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period.
    Imai T; Shiga T; Saruki N; Nishikawa K; Fujita T; Morishita Y
    Can J Anaesth; 1996 Aug; 43(8):812-9. PubMed ID: 8840061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100B as a biomarker of blood-brain barrier disruption after thoracoabdominal aortic aneurysm repair: a secondary analysis from a prospective cohort study.
    Roberts DJ; Hall RI; Wang Y; Julien LC; Wood J; Goralski KB
    Can J Anaesth; 2021 Dec; 68(12):1756-1768. PubMed ID: 34570352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperstimulation of leukocytes by plasma from cardiopulmonary by-pass patients is diminished by morphine and IL-10 pretreatment.
    Stefano GB; Rodriguez M; Glass R; Cesares F; Hughes TK; Bilfinger TV
    J Cardiovasc Surg (Torino); 1995 Feb; 36(1):25-30. PubMed ID: 7721922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma concentrations of interleukin 35 in patients with coronary artery disease.
    Gorzelak-Pabiś P; Chalubinski M; Wojdan K; Luczak E; Duraj I; Mozdzan M; Broncel M
    Arch Med Sci; 2017 Jun; 13(4):778-784. PubMed ID: 28721145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modulation of high-density lipoprotein and cytokine IL-1β and IL-6 levels in patients with dengue].
    Barrientos-Arenas E; Henao-García V; Giraldo DM; Cardona MM; Urcuqui-Inchima S; Castaño JC; Hernández JC
    Rev Peru Med Exp Salud Publica; 2018; 35(1):15-24. PubMed ID: 29924262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemic response to endotoxin--a part of the host-defence mechanism.
    Liao W; Florén CH
    Scand J Infect Dis; 1993; 25(6):675-82. PubMed ID: 8052806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHARACTERISTICS OF ENDOTOXIN ALTERING FRACTIONS DERIVED FROM NORMAL SERUM. I. SEPARATION OF BETA LIPOPROTEINS AND LIPID FROM HUMAN SERUM FRACTIONS.
    YOSHIOKA M; HAMASAKA M; SAITO Y; KONNO S
    Kitasato Arch Exp Med; 1963 Dec; 36():27-36. PubMed ID: 14318779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.